IFPMA Report on Future Antibiotic Pipeline
The IFPMA report “From Resistance to Resilience” underscores the urgent need to address antimicrobial resistance (AMR), a major global health threat leading to millions of deaths annually. The study explores two future scenarios for antibiotic development: without new incentives, only a few treatments progress significantly; with strong incentives by 2025, many more treatments could be developed, significantly reducing AMR-related diseases. Economic incentives, particularly pull incentives, are crucial. The role of small and medium-sized enterprises (SMEs) in research and development is highlighted, with calls for increased policy support to bolster the antibiotic pipeline and enhance global health security.
If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.
